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§ To determine the fractionation scheme and identify
tumor regressions of non-small cell lung cancer
(NSCLC) patients treated with standard-fractionated







Week 1 7/25/2012 5
Week 2 8/1/2012 5
Week 3 8/8/2012 5
Week4 8/15/2012 5
Week 5 8/22/2012 5
Week 6 8/29/2012 5
4DCTs images of 
NSCLC patients were 
imported to RayStation, 











Table 1. Patient total 4DCTs 
with corresponding dates. 
Fig 1. Fractionation assigning.  
Table 2. Completed fractionation scheme. 
MOSAIQ fraction 
dates examined 
and matched with 
4DCTs dates.
Accessed  
MOSAIQ to view 
the treatment 
dates.
I.    Fractionation scheme determination   








• For each patient, four
landmarks were placed at
vessel bifurcations around the
tumor to classify inelastic or
elastic change. Inelastic cases
were defined if the tumor
regressed while the surrounding
normal tissue remains intact,
and elastic regressions were
defined if the tumor regressed
with the surrounding normal
tissue moving concentrically
with the tumor border.
• Physician approved gross
tumor volume (GTV) contours
(purple) in the planning week.
• Using deep-learning based
automatically segmented GTV
contour (green) in the last
week, the GTV volume change
was quantified.
Planning week Last week
Results
Regression, 
go to step 3.
Fig 2. Tumor regression identification in planning week and last week 4DCTs of one NSCLC 
case.
Fig 3. Planning and last week 4DCTs of one NSCLC case with landmarks around the tumor.
I.  Fractionation scheme determination   
• 65 fractionation schemes defined to 
date.  









9.63 5.8 -39% inelastic
11.09 5.04 -54% inelastic
44.22 32.76 -25% inelastic
Table 3. Sample summary of tumor regression 
identification. The rest of the data can be 
provided to the interested reader.   
I. This work will facilitate the
determination of the accumulated
dose at each week where 4DCTs
were taken.
II. The tumor regression identification
will reduce the inaccuracy of image
registrations, improving accuracy
of delivered dose estimation.
References
Step 1 Step 2
Step 3
• Evaluation of the GTV 
percent change.
Future directions
• Improve the robustness of the
identification of the type of regression
for difficult cases where tumor have
non-uniform changes.
• 16 patients have been evaluated for 
tumor response to date.
§ Fractionation regimens are defined in the planning
phase of radiotherapy (RT) to maximize tumor
destruction and minimize damage to surrounding
tissues. However, the planned dose is not accurate
in representing the delivered dose due to inter-
fractional anatomical changes that occur during
treatment, such as tumor regression.
§ Dose accumulation can more accurately represent
the delivered dose. It consists of doses recomputed
on longitudinal images during treatment based on
the delivered fractions.
§ These recalculated doses are then mapped to a
reference image before being summed. The dose
mapping process depends on deformable image
registration (DIR), which establishes a voxel-voxel
correspondence between two images. However, the
precision of DIR can be affected by tumor response,
thus confounding the ability to estimate the total
dose delivered accurately. Tumor response is mainly
divided into inelastic regression: the tissue usually
remains intact and does not move along with the tumor
and elastic regression: the healthy tissue moves
concentrically with the tumor.
§ To our knowledge, this will be the first workflow
in RT to define tumor regression. This will allow
more accurate delivered dose estimation which
can be linked to the toxicity information in follow-
up images, ultimately improving treatment
outcomes.
Work impact
